Literature DB >> 27852858

Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase.

Daniel N Clark1, John M Flanagan2, Jianming Hu3.   

Abstract

Hepatitis B virus (HBV) encodes a multifunction reverse transcriptase or polymerase (P), which is composed of several domains. The terminal protein (TP) domain is unique to HBV and related hepadnaviruses and is required for specifically binding to the viral pregenomic RNA (pgRNA). Subsequently, the TP domain is necessary for pgRNA packaging into viral nucleocapsids and the initiation of viral reverse transcription for conversion of the pgRNA to viral DNA. Uniquely, the HBV P protein initiates reverse transcription via a protein priming mechanism using the TP domain as a primer. No structural homologs or high-resolution structure exists for the TP domain. Secondary structure prediction identified three disordered loops in TP with highly conserved sequences. A meta-analysis of mutagenesis studies indicated these predicted loops are almost exclusively where functionally important residues are located. Newly constructed TP mutations revealed a priming loop in TP which plays a specific role in protein-primed DNA synthesis beyond simply harboring the site of priming. Substitutions of potential sites of phosphorylation surrounding the priming site demonstrated that these residues are involved in interactions critical for priming but are unlikely to be phosphorylated during viral replication. Furthermore, the first 13 and 66 TP residues were shown to be dispensable for protein priming and pgRNA binding, respectively. Combining current and previous mutagenesis work with sequence analysis has increased our understanding of TP structure and functions by mapping specific functions to distinct predicted secondary structures and will facilitate antiviral targeting of this unique domain. IMPORTANCE: HBV is a major cause of viral hepatitis, liver cirrhosis, and hepatocellular carcinoma. One important feature of this virus is its polymerase, the enzyme used to create the DNA genome from a specific viral RNA by reverse transcription. One region of this polymerase, the TP domain, is required for association with the viral RNA and production of the DNA genome. Targeting the TP domain for antiviral development is difficult due to the lack of homology to other proteins and high-resolution structure. This study mapped the TP functions according to predicted secondary structure, where it folds into alpha helices or unstructured loops. Three predicted loops were found to be the most important regions functionally and the most conserved evolutionarily. Identification of these functional subdomains in TP will facilitate its targeting for antiviral development.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  DNA polymerase; RNA binding; hepadnavirus; hepatitis B virus; protein priming; reverse transcriptase; terminal protein

Mesh:

Substances:

Year:  2017        PMID: 27852858      PMCID: PMC5244320          DOI: 10.1128/JVI.01785-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  Hydrophobic residues of terminal protein domain of hepatitis B virus polymerase contribute to distinct steps in viral genome replication.

Authors:  Youn-Chul Shin; Chunkyu Ko; Wang-Shick Ryu
Journal:  FEBS Lett       Date:  2011-11-10       Impact factor: 4.124

3.  Mutagenesis of a hepatitis B virus reverse transcriptase yields temperature-sensitive virus.

Authors:  C Seeger; E H Leber; L K Wiens; J Hu
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

4.  Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.

Authors:  Judit Vörös; Annika Urbanek; Gilles Jean Philippe Rautureau; Maggie O'Connor; Henry C Fisher; Alison E Ashcroft; Neil Ferguson
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Unveiling the roles of HBV polymerase for new antiviral strategies.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

6.  Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Authors:  K Das; X Xiong; H Yang; C E Westland; C S Gibbs; S G Sarafianos; E Arnold
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.

Authors:  H E Blum; E Galun; T J Liang; F von Weizsäcker; J R Wands
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro.

Authors:  Rajeev K Boregowda; Christina Adams; Jianming Hu
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

9.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  7 in total

1.  Multiple roles of core protein linker in hepatitis B virus replication.

Authors:  Kuancheng Liu; Laurie Luckenbaugh; Xiaojun Ning; Ji Xi; Jianming Hu
Journal:  PLoS Pathog       Date:  2018-05-21       Impact factor: 6.823

Review 2.  Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target.

Authors:  Timothy S Buhlig; Anastasia F Bowersox; Daniel L Braun; Desiree N Owsley; Kortney D James; Alfredo J Aranda; Connor D Kendrick; Nicole A Skalka; Daniel N Clark
Journal:  Viruses       Date:  2020-05-22       Impact factor: 5.048

3.  Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.

Authors:  Monique T A de Beijer; Diahann T S L Jansen; Yingying Dou; Wim J E van Esch; Juk Yee Mok; Mariëlle J P Maas; Giso Brasser; Robert A de Man; Andrea M Woltman; Sonja I Buschow
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

4.  Protein phosphatase 1 catalyzes HBV core protein dephosphorylation and is co-packaged with viral pregenomic RNA into nucleocapsids.

Authors:  Zhanying Hu; Haiqun Ban; Haiyan Zheng; Mingliang Liu; Jinhong Chang; Ju-Tao Guo
Journal:  PLoS Pathog       Date:  2020-07-23       Impact factor: 6.823

5.  Novel Genetic Variants of Hepatitis B Virus in Fulminant Hepatitis.

Authors:  Jack Bee Chook; Yun Fong Ngeow; Kok Keng Tee; Suat Cheng Peh; Rosmawati Mohamed
Journal:  J Pathog       Date:  2017-12-19

6.  The E3 Ubiquitin Ligase TRIM21 Promotes HBV DNA Polymerase Degradation.

Authors:  Ting Mu; Xiaoqing Zhao; Yanan Zhu; Hongxia Fan; Hua Tang
Journal:  Viruses       Date:  2020-03-21       Impact factor: 5.048

7.  rt269I Type of Hepatitis B Virus (HBV) Polymerase versus rt269L Is More Prone to Mutations within HBV Genome in Chronic Patients Infected with Genotype C2: Evidence from Analysis of Full HBV Genotype C2 Genome.

Authors:  Hyein Jeong; Dong Hyun Kim; Yu-Min Choi; HyeLim Choi; Donghyun Kim; Bum-Joon Kim
Journal:  Microorganisms       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.